HELIX-2, A Phase II Study of Samatasvir in Combination with Simeprevir, Low Dose Ritonavir-boosted TMC647055+Ribavirin in Treatment-naive or Interferon/ribavirin Treated, Relapsed Genotype 1 HCV-infected Subjects
HEPATOLOGY(2014)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要